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Abstract
Few studies describe the way patient navigation processes may address disparities in treatment and 
follow-up care for medically underserved populations. Using a social ecological framework, we 
analyzed survey assessments of 519 patients completing a randomized navigation trial in 
Appalachia Kentucky to examine patient-reported barriers to follow-up cervical cancer care. We 
also analyzed in-depth interview transcripts with four lay patient navigators in the trial to identify 
barriers to follow-up care and to learn what communication strategies navigators use to 
successfully (or unsuccessfully) help patients navigate around those barriers. Our analysis 
provides insight into how patient navigation may improve adherence to follow-up care through 
assisted uncertainty management. We also discuss opportunities for improving navigator training 
to address disparities in clinical outcomes.
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In 2010, over 4,000 women in the United States died from invasive cervical cancer, a 
disease that is preventable and treatable (American Cancer Society, 2012). Well-
documented disparities based on socio-economic status, race, ethnicity, and quality of health 
insurance are associated with inequalities in cervical cancer detection and care (Freeman, 
2006; Hopenhayn, Bush, Christian, & Shelton, 2005; Wingo et al., 2008). Despite the 
availability of free coverage for Papanicolaou (Pap) test screening and follow-up care, many 
women do not return for follow-up care after abnormal cytology findings and thus risk 
developing cervical cancer.
Women in medically underserved communities, including women in rural Appalachia, are 
less likely than women in more medically advantaged areas to receive the benefits from 
available care (Freeman & Wingrove, 2005). In Appalachian Kentucky, women are more 
likely to die from cervical cancer than women residing elsewhere in the United States 
(Hopenhayn, King, Christian, Huang, & Christian, 2008). From 2005–2009, Appalachian 
women, a predominantly White population, had significantly higher age-adjusted invasive 
cervical cancer (ICC) incidence rates (9.85/100,000 people) than non-Hispanic White 
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women in the United States (7.1/100,000 people; Kentucky Cancer Registry, 2012; 
Howlander, Noone, Krapcho, et al., 2012). The same pattern held for mortality over the 
2005–209 time period: Appalachian Kentucky women had a cervical cancer mortality rate of 
3.5 per 100,000, whereas mortality rate among non-Hispanic White women was 2.1 per 
100,000 (Kentucky Cancer Registry, 2012; Howlander, Noone, Krapcho, et al., 2012). This 
disparity can be explained, in part, by lack of appropriate follow-up treatment after an 
abnormal Pap test and more late-stage ICC diagnosis in Appalachian Kentucky 
(Schoenberg, Baltisberger, Bardach, & Dignan, 2010).
As one method of improving patient follow-up care outcomes, the National Cancer Institute 
has supported the introduction of lay patient navigation programs in medically underserved 
areas to provide guidance and support to an individual with abnormal cancer screening 
results or with a cancer diagnosis. Although variations in definitions of patient navigation 
exist (Dohan & Schrag, 2005; Freeman, 2006), in the present research, patient navigation 
involves a trained lay navigator helping individual patients surmount barriers to health care, 
such as barriers related to insurance or finances, accessing or understanding information, or 
coordination of care. In the current study, the goal of the patient navigation program was to 
help patients secure appropriate and timely care from screening (i.e., evaluating an abnormal 
Pap test) until resolution of treatment.
Kentucky provides access to breast and cervical cancer screening for low-income women 
through the Kentucky Women’s Cancer Screening Program, funded by the Centers for 
Disease Control and Prevention’s Breast and Cervical Cancer Early Detection Program. For 
women participating in the program, the mechanism for receiving treatment and follow-up 
care requires that women receive cancer screening from a local health department. Results 
of Pap testing are not immediate, requiring women whose test results indicate abnormal 
cytology to return for follow-up assessment. This follow-up often involves referral to 
outside providers for OB/GYN screening and appropriate treatment, and this external 
referral often is a barrier to further care. It is at this point of referral that patients may be 
advantaged by the opportunity to connect with a lay navigator to help guide them through 
the follow-up process, ideally through treatment and back to routine care from the health 
department or the specialist provider.
A number of barriers to appropriate and timely care have been identified as factors that 
exacerbate health inequality (Epstein, 2004; Fremont et al., 2003). In the case of individuals 
diagnosed with an abnormal Pap test, barriers related to work-family demands, emotional 
stress, lack of transportation and childcare may be particularly pronounced for low-income 
patients residing in medically underserved communities. Additionally, sociocultural beliefs 
(e.g., medical mistrust) may account for barriers to care in certain subpopulations, including 
Appalachians (Freeman, 2004). Research has demonstrated that patient navigation is an 
effective method to reduce disparities in cancer care for poor and minority populations by 
helping them overcome barriers to access care (Dohan & Schrag, 2005; Freeman, 2004, 
2006). Navigators can provide personal advocacy, local knowledge, and assistance from the 
lay perspective to help patients access health services that they need and overcome barriers 
to obtaining follow-up care (Eggleston, Coker, Das, Cordray, & Luchok, 2007; Jean-Pierre, 
Fiscella et al., 2011; Jean-Pierre, Hendren et al., 2011).
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Previous research on medically underserved populations has used a social ecological 
perspective to explain barriers to women’s receipt of follow-up cervical cancer care 
(Schoenberg, Hatcher, & Dignan, 2008; Schoenberg et al., 2010). According to the social 
ecological model, it is the dynamic interaction among multiple levels of factors, including 
individual, interpersonal, organizational, community, and cultural factors, that contributes to 
the health of a population (Bronfenbrenner, 1977). Research by Schoenberg and colleagues 
(2010) has identified patient-level determinants of follow-up to abnormal Pap tests and has 
found that lack of follow-up care has been associated with being young, having a low 
education level, lacking insurance, fearing cancer, being embarrassed, and lacking 
knowledge about the need for or process of follow-up care. This line of research also has 
detailed a number of organizational factors that are associated with a lack of follow-up care, 
including inadequate medical record documentation, inaccessible location, and poorly 
developed systems for tracking follow-up care (Schoenberg et al., 2010). Finally, some 
research has identified community- and cultural-level factors affecting follow-up to 
abnormal Pap tests, such as rural residence in Appalachia, which often entails resource 
scarcity and strong kinship ties (see Schoenberg et al., 2010).
Although previous work has examined factors at the individual, organizational, community, 
and cultural levels, less attention has been paid to the interpersonal level of influence on 
women’s cervical cancer follow-up care and how interpersonal processes may help women 
overcome socio-ecological barriers to follow-up care. In particular, the interpersonal 
influence of social support remains understudied in the context of patient navigation 
(Breitkopf, Catero, & Berenson, 2004). This is surprising given that one of the key features 
of patient navigation programs is the provision of social support to patients, including 
assistance with information management, tangible needs, and emotional validation (Jean-
Pierre, Hendren et al., 2011).
Navigation programs assume that lay support strategies can improve health equity for 
medically underserved populations (Wells et al., 2008). However, research is needed to 
examine the potential benefits and limitations of navigation support practices in addressing 
barriers to care. Thus, in the present study, we focus on the role of patient navigator 
communication in addressing barriers to patients’ receipt of follow-up appropriate cervical 
cancer care and prevention services. Specifically, we asked the following research questions: 
What factors do Appalachian patients receiving abnormal Pap test results identify as barriers 
to appropriate follow-up care? To what extent do navigators acknowledge and address the 
barriers identified by patients? What communication strategies do navigators use to help 
patients address those barriers? What additional barriers to follow-up care do navigators 
identify, and how do they report addressing them?
Method
Field Sites
We conducted the current research in two Appalachian Kentucky Area Development 
Districts, which included 13 of Kentucky’s 54 Appalachian counties. The counties were 
generally representative of the region: They were highly rural and had low population 
density, families with low socioeconomic status, and a shortage of health care provider and 
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OB/GYN services (see Kentucky Health Facts, 2012). In Kentucky, local health departments 
are charged with providing low-cost or free cervical cancer screening services as part of the 
Kentucky Women’s Cancer Screening Program. Given the high rates of poverty and un- or 
under-insurance, residents heavily rely on state-funded medical care programs. The local 
health departments were thus an ideal venue in which to conduct research on health 
disparities.
Samples
In the present research, we used a purposive sampling strategy to recruit patients into the 
navigation intervention program and to select navigators to interview for the study. For the 
patient participants, eligible women had received an abnormal Pap test result (which 
indicates the presence of abnormal cells but does not provide a diagnosis of cancer or 
dysplasia, a pre-cancerous condition), were residents of Appalachia Kentucky, and were 
able and willing to participate in the study, which entailed completing a baseline survey 
administered in person by a patient navigator at the time of enrollment. Health department 
patients who received an abnormal Pap result from September 2008 to April 2010 were 
eligible to participate in the study. We contacted 656 patients by phone or in person when 
the nurse case manager and navigator team found abnormal Pap results during record 
review. These women were offered enrollment in the project; 41 (6%) women refused, and 
96 (15%) women were considered passive refusals (i.e., women who initially agreed to 
participate but could not be reached again for enrollment). This resulted in a sample of 519 
enrolled patients, ranging in age from 18 to 72 years old (M = 29 years, SD = 11 years).
As the demographic information in Table 1 indicates, the sample was predominantly White 
and was characterized by relatively low levels of education, household income, and 
insurance coverage. The patient follow-up care needs at the time of intake are also reported 
in Table 1. Although one in ten Pap tests indicates some abnormality, most cases are not 
serious. Follow-up recommendations for further evaluation were based on a protocol 
established by the Kentucky Women’s Cancer Screening Program. About half of the patients 
reported that they had decided to follow their provider’s recommendation for follow-up care 
(n = 259, 49.9%).
We also conducted in-depth face-to-face interviews with patient navigators who were 
currently working with patients completing the navigation intervention. The navigator 
participants were adult female residents of Appalachia Kentucky. Due to the embedded 
nature of the navigators as part of a broader community-based research project identified by 
a federal funding number, we have withheld navigators’ demographic information to ensure 
confidentiality (and we do not use pseudonyms to prevent inferences being drawn from 
names). All available patient navigator staff (N = 4) at the close of study enrollment agreed 
to be interviewed as part of summative evaluation activities. (Over the course of the study 
period, many navigators were offered permanent positions in the health department or 
received other full-time employment offers, necessitating ongoing recruitment of new 
navigators to enroll patients. A total of 11 navigators enrolled patients in the intervention, 
with between 4 and 6 navigators recruiting participants at any given time.)
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The present research was part of a larger clinic-randomized navigation project examining 
cervical cancer prevention in Appalachian Kentucky. A research protocol was established 
between each nurse case manager and patient navigator, in which patient navigators would 
review clinic records to identify potentially eligible patients for the research study. All 
patients with an abnormal Pap result were referred for navigation by nurse case managers as 
part of the standard of care provided by the health departments. Although each nurse case 
manager/navigator team had its own approach, navigators followed a general script for study 
enrollment (and phone recruitment if first contact was not made by personal introduction 
after a visit with a nurse in the health department). When possible, navigators spoke with 
patients immediately following a nurse’s disclosure of an abnormal Pap test to inform them 
about the research study (including the $25 gift card incentive) and invite them to 
participate.
After a patient provided informed consent, the navigator asked the patient questions using a 
structured survey protocol and recorded patient responses in real time. Patients were asked 
to provide demographic information and to identify barriers to follow-up care (using a 
yes/no response) from a predetermined list of barriers elicited from prior research 
(Schoenberg et al., 2010). In addition, patients reported whether they had decided at baseline 
(i.e., before receiving navigation services at the close of the meeting) to follow their 
provider’s recommendation for follow-up care. The survey, which took 20–30 minutes to 
complete, was part of the initial navigation meeting, which typically lasted one hour. The 
survey protocol was designed as a formative assessment to allow the navigators to determine 
the most significant barriers to follow-up care; the latter portion of the meeting involved the 
navigator providing informational, logistical, or emotional support to help overcome patient 
barriers to appropriate care. All patients (regardless of clinical trial participation) were 
offered the full range of navigation assistance.
Quantitative Data Analysis
Before developing our in-depth interview protocol for navigators, we analyzed the patient 
survey data using descriptive statistics to explain the nature of the population served by the 
navigation program, and we used inferential statistics to explore the associations between 
population characteristics, patients’ decisions (at baseline) to receive appropriate follow-up 
care, and patient-perceived barriers to follow-up care.
In analyzing the patient survey data, we computed the frequencies of the patient-reported 
barriers to receiving follow-up care, which are presented in Table 2. The most frequently 
cited barriers were lack of insurance and cost, followed by fear of the results and fear of 
pain. Given the availability of low-cost or free follow-up care in Kentucky, the frequency 
with which cost was cited as a barrier to follow-up care evidences the patients’ uncertainty 
about access to this care. Furthermore, the high frequency of fear of the results and fear of 
pain (from treatment procedures) as barriers to follow-up care is an important finding. 
Because HPV infections can lead to uncertainties regarding whether cervical abnormalities 
will recur, women’s fear of the test results and fear of pain may be due to past experiences 
with treatment procedures, and the desire to avoid (by not pursuing care) additional follow-
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up Pap tests, diagnoses, and treatment. This fear may influence some women to maintain 
their uncertainty about their diagnosis and treatment (by not pursuing care) rather than 
reduce their uncertainty (by pursuing care). Thus, we decided to further investigate patient 
uncertainty experiences in the interviews with navigators.
In the second stage of quantitative analysis, we computed chi-square statistics to determine 
if there were any associations between patient demographic factors (see Table 3) or barriers 
to follow-up care (see Table 2) and whether the patient had decided to pursue appropriate 
follow-up care as recommended by her provider at the time of the baseline survey. There 
were no significant associations between appropriate follow-up care and age, education, or 
household income. These findings suggest that demographic factors do not significantly 
differentiate those patients who stated a decision to pursue appropriate follow-up care (i.e., 
by already having had an appointment or by scheduling one) from those who did not among 
women sampled in these health departments. We also found that most of the patient-reported 
barriers to follow-up care did not significantly distinguish between patients who reported a 
decision to pursue appropriate follow-up care and those who did not. In fact, the results from 
this analysis indicated that significantly more women who reported that clinic hours were a 
barrier to receiving care actually stated a decision to pursue appropriate follow-up care, and 
significantly more women who indicated that follow-up care was not a problem had not, at 
the time of baseline assessment, decided to pursue appropriate follow-up care.
These findings indicate that the logistical and procedural factors that many patient 
navigation programs assume are barriers to follow-up care are indeed common, but they 
may not necessarily be associated with the decision to receive appropriate follow-up care 
following an abnormal Pap test result. This suggests that there are other factors that are 
deterring women from receiving follow-up care. The goal of our qualitative approach was to 
further our understanding of these other factors. We used in-depth face-to-face interviewing 
to examine to what extent navigators acknowledged patient-reported barriers, to identify 
what additional barriers not explicitly considered in the survey were perceived by navigators 
as relevant to the patients’ receipt of care, and to learn what communication strategies the 
navigators used to successfully or unsuccessfully help patients address those barriers. The 
use of quantitative and qualitative data collection and analysis methods allowed us to 
triangulate findings from these parallel protocols.
Interview Protocol
The four patient navigators were each interviewed by one of two of the authors (EC and AS) 
after providing informed consent. No incentive was provided for participation as the 
navigators participated in their role as project employees. The interviews followed a semi-
structured protocol designed to elicit narratives focused on the navigator’s perceptions of 
what helped or hindered patients in pursuing follow-up care for abnormal Pap tests. The 
interview protocol was based in part on the most common patient-reported barriers that 
influence navigation success (see Table 4). In addition, we also explored additional barriers 
to patient receipt of navigation and appropriate care (such as patient uncertainty), including 
navigators’ difficulties communicating with patients (e.g., “Can you tell me about a time 
when a patient wasn’t willing to follow up after her diagnosis and you had a hard time 
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navigating her through the follow up process?”) and the challenges to overcoming patient 
obstacles to follow-up care (e.g., “Can you tell me about a time when a patient did not get 
follow-up care no matter what you did to help?”). Finally, we explored how navigators 
successfully used communication to help patients overcome barriers to care (e.g., “Can you 
tell me about a time when a patient got follow-up care because of something you did or said 
to help?”). The interviews took place in each navigator’s office and lasted between 55 and 
80 minutes. The interviews were audio-recorded and professionally transcribed verbatim.
Qualitative Data Analysis
We analyzed the transcripts of the navigator interview data using qualitative descriptive 
analysis, a low-inference method designed to gain an accurate accounting of a phenomenon 
in the “everyday terms” of the phenomenon and an accurate understanding of the meanings 
participants attach to the phenomenon (Sandelowski, 2000, p. 336). Two of the authors (EC 
and AS) independently examined the transcripts and then met to discuss general emergent 
themes in the navigators’ narratives about difficult and rewarding cases of navigation. After 
refining the themes through discussion, the two authors returned to the transcripts to code 
for how patient uncertainty and navigator support were related to follow-up care successes 
and difficulties. The authors met again to reach consensus on whether the interviews 
identified additional barriers to follow-up care that were not considered as part of the 
baseline survey and what communication strategies navigators used to help patients address 
barriers to follow-up care.
Results
The navigators had no difficulty recounting their successful and difficult cases navigating 
patients to appropriate care. Their stories confirmed patient-reported barriers to follow-up 
cervical cancer care and identified additional barriers faced by Appalachian women. We 
identified three themes in the navigators’ accounts: (a) Logistical barriers to care can mask 
patient uncertainties about care outcomes, (b) Navigators strategically use certain and 
uncertain information about cervical abnormalities to motivate patients to receive 
appropriate follow-up care, and (c) Relational and personal value conflicts pose challenges 
to patient navigation.
Logistical Barriers to Care Can Mask Patient Uncertainties About Care Outcomes
Patient navigators were well-prepared to communicate with patients to resolve logistical 
barriers to care (i.e., barriers related to the procurement, fulfillment, and maintenance of 
appropriate health care). Because this was a low-income population residing in a medically 
underserved region with limited access to providers, all patients needed to receive follow-up 
care outside the known health department setting. According to the navigators, patients 
commonly expressed concerns about who would treat them and where they would get 
treatment:
A lot of women doesn’t want a female doctor, so. Yeah, a lot of women won’t want 
a female, they’ll only want a male. And then a lot of women are the opposite, 
they’ll only want a female and not a male, and then we have one male doctor here, 
so that kind of makes it difficult with scheduling.…little things like that that bother 
Cohen et al. Page 7













them more than having the actual Pap, you know, it’s just social issues, not 
knowing their way around the office there at [clinic name], that scares people 
because of the hallways. (Navigator 4)
Logistical barriers were issues that the navigators felt equipped to handle. They knew the 
terrain of the buildings that patients would visit and could provide assistance in bringing 
patients to their appointments and scheduling certain providers.
Other logistical barriers related to issues of cost: “They wonder how they’re going to pay. 
They want to know how it’s going to be paid for” (Navigator 4). The navigators were able 
not only to help patients understand how payment works so that the patients would accept 
free or low-cost follow-up care, but they also completed many of the tasks associated with 
securing payment for care, such as completing and faxing reimbursement paperwork to 
clinics.
Another logistical barrier to follow-up care involved scheduling (and rescheduling) 
appointments. The navigators often acted as the go-between for patients and their nurse case 
managers, who perceived missed appointments as a burden on their caseload. What 
appeared to be a logistical concern, however, could mask a patient barrier to follow-up care 
rooted in uncertain knowledge about screening outcomes. For example, navigators perceived 
that underlying motivations for missed appointments often included women’s uncertainty 
related to and fear of confirming a cancer diagnosis or fear of pain (which is consistent with 
the patient-reported barriers to care from our quantitative analysis). Navigators believed that 
some patients indicated that they had scheduling barriers when the real barrier was fear of a 
cancer diagnosis. As one navigator recounted:
Some get lost to follow up because they just, you know, they promise the moon. 
And it amazes me, I’m like, “Here you have something very treatable, you know, 
caught early and you’ll just.” It’s like [patients think], “If I just don’t keep the 
appointments, I’ll just, you know, it’ll go away.” (Navigator 2)
Uncertainty is inevitable in the experience of women with a history of abnormal Pap tests 
because the course of infection in women’s bodies is unpredictable. Navigators recognized 
this uncertainty as a barrier to care and reported feeling ill-equipped at times to help women 
live with the uncertainty of their diagnosis, which would necessarily persist until follow-up 
care was received. One navigator explained how her attempts to remove logistical barriers to 
care (e.g., scheduling) were unsuccessful in helping one woman get follow-up care because 
she still could not help the patient address the fear of confirming cancer:
They go to the GYN and then they don’t go back for other follow-ups. But I’ve had 
one woman, she come in here, she was in her 40s probably, and she came in and 
got her paperwork and said, you know, promised up and down she was going to go 
to the GYN. She missed her appointment. I scheduled it probably six or seven 
times. Usually we only have to schedule them three times and then we drop them, 
but I tried six or seven times. I even called her, you know, “If you need somebody 
to take you, you know, we can get you, try to find you some assistance to help take 
you up there,” and she’s, you know, with her work schedule, she said she just 
wasn’t able…She had histories and her mom had, like, breast cancer, and she was 
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just afraid that, you know. I’m like, “It was her breasts, you know, this is cervical, 
you know, it can turn into cancer, too.” You know, you just try to tell, talk to them, 
but sometimes they don’t want to listen. (Navigator 1)
One strategy navigators reported using to address uncertainty about a cancer diagnosis was 
to talk with women about the importance of prioritizing their health, particularly if they 
mentioned childcare, work, or lack of time as logistical barriers to follow-up care. 
Navigators also briefed women that the odds of survival are better for women who detect 
abnormalities sooner and get treated quickly to encourage them to keep their follow-up 
appointments. One navigator said that she would “share some personal stories with them” to 
emphasize the importance of early detection. For instance, she would tell the story of “a 
little girl that didn’t come back and her Pap was one code, and then when it came back it 
was, you know, a lot worse.…Just to try to give them a perspective of what could happen if 
they didn’t…keep their follow up” (Navigator 3). The navigator framed finding out about 
the diagnosis later rather than sooner as risky behavior because the abnormality can get 
worse if patients wait to follow up.
Navigators reported that occasionally they would see patients who sought to replace 
uncertainty related to their Pap test result with certain denial about the reliability of the Pap 
test or their HPV diagnosis. As one navigator explained:
I had a lady in [county name] who refused, who just flat out refused, “No, I will not 
have a colpo[scopy] done”…I don’t know if she didn’t trust our services or if she 
just refused to, you know, I don’t know. She didn’t think ours [Pap test] was 
accurate….She had every reason, she qualified for a medical card, she had a part-
time job working in a nursing home, she had the time, she had the month because 
she was qualified. I don’t know. And to beat all, she was an LPN, so you would 
think of all people, she would understand the importance of it but she, she didn’t. 
(Navigator 4)
By contrast, other patients sought to replace uncertainty about their Pap test results by 
embracing the certainty of one normal follow-up Pap test result and ignoring the need for 
subsequent regular follow-up Pap test over time:
There’s the protocol of how many normals, how many…normal Pap tests they’ve 
got to get….If maybe that first one’s good, it’s like [patients think] “Woohoo! Out 
of the woods, you know, I’m good.” And [they] don’t come back. (Navigator 2)
In summary, navigators experienced success in helping patients address logistical barriers to 
follow-up care, but when the logistical barriers masked deeper uncertainty about care 
outcomes as barriers to follow-up care, navigators experienced difficulty in helping patients 
secure follow-up treatment. Navigators identified thisuncertainty rooted in the fear of results 
and fear of pain as one potentially significant barrier to follow-up cervical cancer care. 
Moreover, the navigators reported that, in general, they did not have well-developed 
communication strategies for addressing such uncertainty as a barrier.
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Navigators Strategically Use Certain and Uncertain Information about Cervical 
Abnormalities
Patient navigators identified a number of uncertainties about the nature of HPV infection 
and cervical abnormalities. Such uncertainties, which arise from patient misunderstanding of 
Pap tests and treatment processes, can act as barriers to care. All four navigators in the 
current study explained that they directed patients right back to the nurse case manager 
when patients had medical concerns, and each described how they were careful to not give 
patients medical advice. One navigator explained, “They may think I’m a nurse, and I sit 
back in clinics…but I am not a nurse…and I’m certainly not going to give you medical 
advice” (Navigator 2). However, the navigators’ lay understanding of abnormal Pap test 
results was critical in helping women manage uncertainties related to the nature of their 
personal diagnosis or treatment:
They want to know how bad it is. Is it kind of bad or is it real bad, because if it’s 
kind of bad, they probably, they’re like, “Okay, I won’t worry about it.” So I 
always tell everybody, “It’s not bad at all if you get it treated, you know, if you 
work with us here.” But they want to know how, why, how and why they have it. 
They want to see a visual. They want to see what an abnormal Pap looks like and 
what a regular Pap looks like, and they want to, they want to know if it looks just 
like theirs or if theirs looks worse. Then it’s just, I don’t ever show them that 
because there’s no, there’s no way of knowing exactly what it looks like, but 
people like to see that visual. They ask me about what their next step is, and that’s 
one of the main things I do is help them to get their, go to their next step. I have 
some booklets and brochures on colpos and LEEPs and biopsies, and I have 
pictures of the tools used, pictures of what, you know, what’s going to be done, and 
so they like to see that, they like to look at that. (Navigator 4)
In addition to referring patients back to nurse practitioners, the navigators frequently 
reviewed standard brochures and booklets designed for the lay patient audience. By acting 
as a gatekeeper of visual information (e.g., letting patients see pictures of treatment tools but 
not of normal and abnormal Pap tests), navigators tried to help their patients resolve 
uncertainties about follow-up cervical cancer care. Reviewing these materials provided more 
information to patients and thus increased certainty, but this informational approach did not 
necessarily help patients in evaluating what the diagnosis would mean to them personally.
Although navigators were trained to show pictures or provide materials approved by the 
health department nurse case managers and project staff, occasionally patient navigators 
admitted to going “off script”:
It’s hard for me to explain something to somebody that I’ve not went through 
myself….I don’t know what it’s like to be in their shoes because I’ve never had 
nothing like that. But, you know, I just try to talk to them, make them feel 
comfortable, you know. You know, I tell them they’re not going to do nothing, you 
know, like, if something’s painful, they’ll usually knock you out, you know. It’s 
not going to be that bad on you. I mean, I always tell them, you know, it’s sort of 
like a Pap. (Navigator 1)
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This navigator’s story demonstrates how she, as a layperson, had uncertainty about the 
follow-up procedures because she had not experienced them herself. She tried to diminish 
the uncertainty about how painful follow-up procedures would be by substituting her more 
certain, lay knowledge about Pap tests. She “knew” that because patients do not receive 
anesthesia for these treatments, it was probably not “too bad.” However, this rhetorical 
strategy to communicate certain “lay knowledge” to manage her patients’ uncertainty 
resulted in her relaying misinformation. She told patients that the medical procedures are 
like a Pap test, which uses a small, soft brush to collect cells from the cervix and vagina and 
is not analogous to a cervical colposcopy and punch biopsy surgical procedure, which often 
include use of local anesthetic and carry some unique risks of pain and distress, particularly 
for young women (Moyer, 2012).
Navigators reported that many patients experienced uncertainty related to what it meant to 
be HPV-positive and to live with a cervical abnormality. It is important to note that HPV 
DNA testing is not always part of health department Pap procedure. But, given that HPV is 
responsible for more than 99% of cervical cancer cases (Walboomers et al., 1999), the 
women who received an abnormal Pap test result often asked navigators about the meaning 
of the Pap test and HPV diagnosis. Many women asked navigators for help understanding 
their test results when they didn't understand their risk factors: “You know, you have, if you 
have a married woman who comes in who, you know, doesn’t smoke and doesn’t, you 
know, has one partner, she’s concerned because she’s, you know, she’s, ‘How is this 
possible?’” (Navigator 4).
Several navigators reported that these uncertainties about being HPV-positive and the 
outcomes associated with follow-up care were linked to women’s concerns about the stigma 
associated with sexually-transmitted infections. One navigator reported that she tried to 
make women feel that they were not individually responsible for their diagnosis so that they 
would be more likely to pursue follow-up care:
That’s kind of hard to deal with because you don’t know what’s going on inside 
their body, they don’t know what’s going on inside their body, and trying to 
explain it to them is kind of hard because society has put it on everybody that if you 
have anything wrong in that area of your body, it’s because you had too many 
sexual partners, basically. So they come in here and they feel ashamed and dirty 
that they have an abnormal Pap and that doesn’t, it doesn’t always mean, you 
know, it’s in your genes, it’s hereditary, your mother, your grandmother could’ve 
had some problems and you just didn’t know about it because they didn’t go to the 
doctor. (Navigator 4)
Navigators talked about the abnormal Pap test results in lay language to help women avoid 
stigma and reframe their abnormal Pap tests results as an opportunity for early cancer 
detection and treatment. In using the certainty of medical information about HPV to help 
patients resolve their uncertainty about what it meant to be HPV-positive, the navigators 
maintained strategic ambiguity about the cause of the diagnosis (sexually or genetically 
transmitted) to help encourage patients pursue follow-up care.
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Relational Barriers and Personal Value Conflicts Pose Challenges to Navigation
Navigators reported that they experienced difficulty in helping patients manage relational 
barriers (i.e., barriers related to patients’ relationships with others) and patients’ personal 
values that they perceived conflicted with receipt of follow-up care. Navigators described 
how abnormal Pap test results could pose relationship difficulties for patients given the 
women’s lay understanding of an abnormal Pap as resulting from a sexually transmitted 
infection. One navigator recounted how one of her patients said:
“I don’t know how I got this abnormal Pap….He told me it was from sitting on 
toilet seats.”...You know, her husband accused her of sitting on a dirty toilet seat 
and getting an abnormal Pap because he was, you know, she thought that he was 
cheating and he said he wasn’t. (Navigator 1)
Navigators tried to resolve this relational uncertainty by providing information about HPV:
I tell them that, you know, I’m not a nurse but let me give you what I know about 
it; here’s some, you know, some pamphlets on HPV….It is sexually transmitted, it 
is a virus, and just try to explain it to them the best that I can, and then if it that 
doesn’t satisfy them, then I will let the nurse talk to them again about it. But there 
are a lot of questions that do arise about, arise about HPV….The thing that gets me 
the most about HPV is they want to immediately blame the person that they’re 
with. You know, someone, it can lay dormant in your system for a long time and 
then show itself….I can’t say that it’s not them but I try to explain to them, “Hey, it 
could be someone else. Just don’t go home and, you know, immediately start, you 
know, jumping on him.” (Navigator 3)
Each of the navigators told similar stories, explaining that often it was personally difficult 
for navigators to speak with women about the relational implications of their diagnosis:
The first thing they think is their spouse has cheated on them, they want to know 
who they got it from or where they got it from, and you try to explain to them it 
doesn’t always mean that, and it’s just really hard giving them that information, 
especially if they need to have a hysterectomy and they want more kids. It’s so sad, 
you know. You have 25-year-olds having hysterectomies, so that’s really, that’s 
really hard for me is breaking that information to them. I don’t like to be the bearer 
of bad news….It just breaks my heart. I get too involved personally. (Navigator 4)
Each navigator also reported cases when the responses (or perceptions of responses) of 
patients’ loved ones were potential obstacles to follow-up care. Patients reported actual 
instances of stigmatizing behavior after they talked with family members about their 
abnormal Pap test result or HPV infection and need for treatment. In extreme cases, 
controlling and interfering spouses made it difficult for the navigators to ensure that women 
received appropriate follow-up care:
I had a patient that, she had an abnormal Pap, and we brought her in for counseling, 
and it was a GYN referral. Well, we tried to schedule her appointment and she 
missed it….I called her…trying to reschedule it and she said that her husband 
wouldn’t let her go. I was like…“Is there any way I can reschedule it?” And she 
said no. She said—at the time, “my boyfriend”— “My husband won’t let me go.” 
Cohen et al. Page 12













She said, “I don’t want to reschedule it this time,” and hung up the phone. 
(Navigator 1)
Alternatively, there were times when the patients’ husband was present during the 
navigation process itself, which created a difficult relational dynamic for the navigators to 
manage.
And also a lot of the men, be it their husband or partner, are also involved and sit in 
there….They [the patients] seem more guarded in what they say and they kind of 
defer to the man, and I think that’s kind of, kind of sad sometimes. (Navigator 2)
Navigators expressed regret that they did not have communication strategies that they felt 
could help women in relationships with partners who interfered in the navigation process.
Navigators also reported difficulties addressing cases when patients had uncertainties related 
to how Pap testing and follow-up care fit within a patient’s faith-based value framework. 
Although navigators explained how a Pap test was a means of early cancer detection, some 
women’s religious convictions inhibited them from relying on medical treatment. One 
navigator told the story of her patient’s willingness to refuse traditional treatment in favor of 
prayer:
I had a lady that was a big-time Christian. She had an abnormal Pap. She came in 
and she told us upfront she wasn’t getting no follow-up care because the Lord was 
going to take care of her. She thought…the Pap was it. She said she’ll come in next 
year for her repeat, her annual. And that was it….With that lady in particular, I got 
[the nurse case manager], you know, to come to me and assist me. (Navigator 1)
Although this woman’s religious convictions were not necessarily typical among patients, 
the story shows that the patient navigator was not comfortable addressing this barrier to care 
where a patient’s values conflicted and interfered with their follow-up care (and the 
navigator’s goals).
Discussion
We used a social ecological perspective to examine the interpersonal level of support 
provision by lay patient navigators in cervical cancer prevention efforts in a medically 
underserved region. By examining barriers to cervical cancer follow-up care after an 
abnormal Pap test result among women living in Appalachia Kentucky from the perspective 
of patients and their lay navigators, our analysis demonstrates how patient navigators 
provide support to women in managing their uncertainties related to their health. The 
navigators were well-trained to problem-solve logistical barriers to receiving follow-up care. 
However, the navigators encountered conversations in which they lacked accessible 
communication strategies to address patient uncertainties that posed barriers to getting 
appropriate follow-up care.
Our finding that navigators helped patients manage their uncertainties is consistent with the 
conceptualization of social support as assisted uncertainty management (Brashers, 2001, 
2007). Consistent with previous research, our analysis found that patient navigators 
supported patients in managing their uncertainty by assisting in information seeking or 
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avoiding, providing instrumental support, giving acceptance or validation, encouraging 
perspective shifts, and normalizing disease-related experiences (Brashers, Neidig, & 
Goldsmith, 2004; Scott, Martin, Stone, & Brashers, 2011). There is evidence that support 
from others also can interfere with uncertainty management in a variety of ways, such as by 
creating uncertainty about the relationship between the support provider and recipient, 
introducing support provider’s own uncertainty as something to be managed, or carrying 
obligations to respond to the support in a certain manner (Scott et al., 2011).
On the basis of our findings, patient navigators appear to be uniquely positioned to offer 
support by providing helpful aspects of support to patients without incurring many of the 
costs entailed when family members or friends provide support. However, support from lay 
navigators is not without its own costs to the navigators, who reported experiencing 
frustration when they were unsuccessful in helping a patient or emotional distress when they 
had to deliver bad news. Furthermore, the support offered by lay navigators provides unique 
advantages compared to support from health care providers because the navigators (who are 
not medically trained) can assist the patient in receiving medical care without being 
responsible for the patient’s diagnosis and treatment, which therefore allows navigators to 
play more of an advocacy role on behalf of patients (see Freeman, 2006; Steinberg et al., 
2006).
Implications for Developing Patient Navigation Communication Strategies
The empirical observations from this study and relevant conceptual insights can be 
practically applied to suggest a number of less problematic, more helpful lay navigation 
communication strategies than those reported by navigators in the current research. First, to 
communicate effectively with their patients, health care providers must take into account the 
more abstract barriers to equal access to treatment options for Appalachian women beyond 
mere logistical considerations. Recognizing and responding to women’s logistical barriers to 
cancer inequities requires connecting individuals from medically underserved communities 
with the material resources that a lay navigator can help access. The navigators in our study 
reported making efforts to match patients with a provider who would meet their needs or 
gender preferences, help them manage the paperwork to ensure adequate and timely 
payment for care, and provide lay explanations about the nature and meaning of an abnormal 
Pap test to facilitate informed follow-up care decisions. Here, the successes of navigation are 
abundantly clear: Navigators bridged gaps to help patients understand recommendations 
from health care providers, negotiate bureaucracy, improve knowledge of screening 
procedures, and overcome self-efficacy barriers (e.g., cost, availability, time). However, 
findings from the present study indicate that lay navigators may not be as well-equipped to 
help patients address barriers related to deeper uncertainties about cervical cancer and its 
treatment.
Second, effective patient navigation requires that navigators match appropriate HPV and 
cervical cancer information to patients’ cultural understandings of disease. We found that 
the coping strategies navigators use to deal with particular uncertainties may exacerbate 
women’s misunderstanding of HPV and cervical cancer treatment by perpetuating 
misinformation. Our data suggest that navigators would benefit from witnessing follow-up 
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procedures before discussing the nature of those procedures with patients. If a navigator 
herself lacks the lay knowledge to provide sound advice, scripts might be developed with the 
cooperation of experienced patients and medical professionals to avoid misinformation from 
being relayed.
Third, we found that navigators perceived partner involvement to be a barrier to care for 
women in interfering and controlling relationships. Navigators easily identified cases of 
noncompliance and missed appointments that stemmed from these partner control tactics, 
but they lacked communication strategies to run interference against these tactics, indicating 
that lay navigation training programs would do well to include training to equip navigators 
to help patients talk with interfering partners.
Fourth, this analysis identifies how patient values may become barriers to follow-up care 
and therefore need to be addressed in the health care interaction. It would likely prove useful 
for lay navigators to be trained in using communication strategies that are sensitive to their 
patients’ spiritual sensitivities. As Cohen (2009) has argued, “faith in a higher being or 
spirituality may be a constructive resource for individual optimism or inspiration to confront 
cancer fears” (p. 412), but this constructive potential can only be leveraged in patient 
navigation if the navigators are equipped to help frame women’s spiritual values as 
consistent with (and not contradictory to) follow-up care.
Finally, the current research reveals that some uncertainties cannot be adequately managed 
by lay patient navigation. We found that the navigators helped patients evaluate their 
uncertainty by using certain and uncertain knowledge strategically and privileging some 
forms of uncertainty over others to reframe patients’ abnormal Pap test results. Such 
navigator communication can help negotiate lay understandings of abnormal Pap testing, but 
this can come at the cost of medical precision. Some misinformation and miscommunication 
could reify inappropriate lay understandings of HPV, cervical abnormalities, and follow-up 
treatment processes, which could unduly burden a community already confronting health 
inequities. It is important to train lay navigators to defer to medical personnel and to develop 
lay support strategies for helping patients to manage uncertainty when they lack sufficient 
knowledge so that they do not resort to using certain (but incorrect or misapplied) 
information as their only available means for helping patients resolve unwanted uncertainty.
Limitations and Future Research
Lay patient navigation offers a promising strategy for health departments to improve the 
rates of patient adherence to appropriate follow-up care protocol after an abnormal Pap test 
result. Furthermore, patient navigators can provide timely and appropriate technical, 
relational, informational, and material support to medically underserved patients confronting 
daunting barriers to follow-up screening, diagnosis, and treatment. Clearly, the growth in 
support for navigation programs by the National Institutes of Health, the Health Services 
Research Administration, the American Cancer Society, and other organizations has resulted 
in a clear “first wave” of navigation research focused on logistical and procedural problems 
for effective navigation program adoption. As a result, navigation programs, including the 
one considered in the current investigation, have been developed with a focus on training lay 
people as community health workers who have the local cultural knowledge that gives them 
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the expertise to identify and address patients’ apparent logistical, procedural, and other 
practical barriers to care.
However, the present research suggests that there is another layer of barriers to appropriate 
follow-up cervical cancer care. Indeed, this additional layer is much less concrete than the 
procedural layer and will therefore be more difficult to address. Patient navigators may be 
able to address more abstract (i.e., uncertainty-related) barriers to care, but further research 
is needed to identify how to manage these uncertainty-related barriers with navigator 
communication skills training. Additionally, future research may consider strategies to help 
navigators identify women in interfering relationships earlier in the clinical context. Some 
health departments have adopted the practice of screening for domestic abuse and offering 
assistance accordingly. It is also important to consider whether using trained social workers 
or health care providers may improve navigation outcomes in cases where there may be 
relational interference.
One limitation of the study is that our findings are derived from self-report patient data and 
recollections from the navigators. However, the consistency between these two sources of 
data strengthens our interpretation of the findings. Additionally, at the time of the research 
study, it was a common requirement for women in the clinics to receive a Pap test before 
receiving birth control pill prescriptions. This is no longer a requirement given the most 
recent iteration of the U.S. Preventive Services Task Force guidelines for cervical cancer 
prevention. However, birth control is still a common motivating practice for women coming 
to the clinic for “well-women” visits. Clearly, that there is no similar motivation for follow-
up care after abnormal Pap testing is a consideration for future research. If the effect of 
changing the U.S. Preventive Services Task Force guidelines results in fewer, less regular 
Pap tests in a medically underserved population, then women who receive those less regular 
Pap tests will have fewer contacts with health department personnel and fewer opportunities 
to be navigated to appropriate care.
From a communication perspective, patient navigation offers an important opportunity to 
address patient uncertainties that may contribute to health care inequities. Navigating 
patients to appropriate care in a medically underserved environment is critical to reducing 
health disparities. The present findings from quantitative and qualitative observations 
indicate that improved access to care alone is not a sufficient strategy to improve health 
equity. Successful patient navigation programs must operate with respect for the 
interpersonal communicative management of uncertainty that can facilitate effective 
adherence to provider recommendations for follow-up cervical cancer care.
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Table 1
Patient Demographics
Demographic factor n (% of total N)
Age
  18–29 343 (66.1%)
  30–39 90 (17.3%)
  40–49 52 (10.0%)
  50–59 20 (3.9%)
  60+ 14 (2.7%)
Education
  Grade school 11 (2.1%)
  Middle school 104 (20.0%)
  High school 383 (73.8%)
  College 17 (3.3%)
  Graduate school 4 (0.8%)
Household income / year
  <$10,000 213 (41.0%)
  $10,001–$20,000 151 (29.1%)
  $20,001–$30,000 53 (10.2%)
  $30,001–$40,000 27 (5.2%)
  $40,001–$50,000 10 (1.9%)
  $50,000+ 18 (3.5%)
Ethnicity
  White 499 (96.2%)
  Black 5 (1.0%)
  Other 15 (2.9%)
Medically insured
  Yes 296 (57.0%)
  No 222 (42.8%)
Follow-up care needed
  GYN referral 267 (51.5%)
  Treatment (e.g., LEEP, laser) 246 (47.4%)
  Colposcopy 233 (44.9%)
  Repeat pap test 112 (21.6%)
  Biopsy 2 (0.4%)
Note. Percentages do not add to 100% because some women received multiple recommendations for follow-up care.
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Table 3
Patient Demographics Were Not Associated with Decision to Pursue Follow-up Care
Demographic
factor
Decided not to pursue
follow-up care at baseline
n (% of total N)
Decided to pursue appropriate
follow-up care at baseline
n (% of total N)
χ2 Φ
Age 5.19 .10
  18–29 174 (33.7%) 168 (32.6%)
  30–39 45 (8.7%) 45 (8.7%)
  40–49 26 (5.0%) 25 (4.8%)
  50–59 5 (1.0%) 15 (2.9%)
  60+ 7 (1.4%) 6 (1.2%)
Education 4.91 .10
  Grade school 6 (1.2%) 5 (1.0%)
  Middle school 48 (9.3%) 56 (10.9%)
  High school 195 (37.8%) 186 (36.1%)
  College 8 (1.6%) 8 (1.6%)
  Graduate school 0 (0.0%) 4 (0.8%)
Household income/year 9.25 .13
  <$10,000 101 (19.6%) 111 (21.5%)
  $10,001–$20,000 70 (13.6%) 79 (15.3%)
  $20,001–$30,000 24 (4.7%) 29 (5.6%)
  $30,001–$40,000 18 (3.5%) 9 (1.7%)
  $40,001–$50,000 7 (1.4%) 3 (0.6%)
  $50,000+ 9 (1.7%) 9 (1.7%)
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Table 4
Patient-reported Barriers Informed Interview Questions for Lay Patient Navigators
Patient-reported barrier to
follow-up care Interview questions for navigators
Lack of insurance
Cost




What kinds of things do you say to a woman who is afraid that a biopsy will be painful or will reveal a 
problematic diagnosis?









How do you respond when a patient says that it would help her seek follow-up care if she had more reliable 





Place of follow-up care
Lack of respect from provider
Lack or trust in provider
Can you tell me a story about a patient who was diagnosed with an abnormal Pap but didn’t believe the 





When a woman receives a diagnosis of abnormal Pap, but doesn’t understand what that means or doesn’t 
think that follow-up care is important, what do you say to explain the diagnosis and follow-up care?
Physical health When a woman says that she can’t pursue follow-up treatment because she has other, more pressing health 
concerns, what do you say to her?
Lack of family support How do you respond when a patient says that it would help her seek follow-up care if she had more family 
support
Follow-up care is not a problem Can you tell me a story that sticks out in your mind about a woman who needed follow-up treatment, who 
you helped receive it?
J Commun. Author manuscript; available in PMC 2016 March 28.
